Advertisement

Biology Bulletin

, Volume 45, Issue 2, pp 155–159 | Cite as

Antitumor Activity of Probiotic Bacteria and the Bacterial Association in the Tumor Growth Model and in Cell Culture

  • I. A. Ratnikova
  • N. N. Gavrilova
  • K. Bayakyshova
  • Z. Zh. Turlybaeva
  • L. A. Kosheleva
  • N. M. Utegenova
Microbiology
  • 19 Downloads

Abstract

Strains of lactic acid and propionic acid bacteria and the A-5 bacterial association composed of the Lactobacillus brevis B-3/A-26, L. plantarum 2v/А-6, L. plantarum 14d/I, and Propionibacterium shermanii 2/10 cultures in equal proportion exhibiting high antitumor activity have been selected using the fungus Fusarium bulbigenum var. blasticola tumorlike growth model. L. acidophilus 27w, L. plantarum 2v/I, 2v/A-6, and 22A-310, L. fermentum 127A-4, L. cellobiosus 7n, L. salivarius 39n, P. shermanii 2/10, and the А-5 association were shown to inhibit completely the tumorlike growth of the fungus when present as 2% native cultures in the nutrient medium. The high antitumor activity of the A-5 association comparable with that of the therapeutic agents doxorubicin and cyclophosphamide was confirmed using human tumor cell lines originating from different organs (HepG2, RD, and H9). It has been demonstrated that the bacterial strains comprising the A-5 association were resistant to doxorubicin and methotrexate, the antitumor drugs tested.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adams, R., Methods of Cell Culture for Biochemists, Moscow: Mir, 1983.Google Scholar
  2. Biffi, A., Coradini, D., Larsen, R., Riva, L., and Di Fronzo, G., Antiproliferative effect of fermented milk on the growth of a human breast cancer cell line, Nutr. Cancer, 1997, vol. 28, pp. 93–99.CrossRefPubMedGoogle Scholar
  3. Brashears, M.M., Gilliland, S.E., and Buck, L.M., Bile–salt deconjugation and cholesterol removal from media by lactobacillus casei, J. Dairy Sci., 1998, vol. 36, pp. 281–301.Google Scholar
  4. Doronin, A.F. and Shenderov, B.A., Funktsional’noe pitanie (Functional Nutrition), Moscow: Grant”, 2002.Google Scholar
  5. Droganov, M., Cell Cultures. Theory and Technique, Plovdiv: VAP, 2004.Google Scholar
  6. Farkas-Himsley, H. and Cheung, R., Bacterial proteinaceous products (bacteriocins) as cytotoxic agents of neoplasia, Cancer Res., 1976, vol. 36, no. 10, pp. 3561–3567.PubMedGoogle Scholar
  7. Gavrilova, N.N., Berezin, V.E., Ratnikova, I.A., and Kadyrbaev, Zh., A mean for prevention of Newcastle disease, RF Preliminary Patent no. 17845, 2006, Byul. Izobret., 2006, no. 10.Google Scholar
  8. Glushanova, N.A., Biological properties of lactobacilli, Byul. Sib. Med., 2003, no. 4, pp. 50–55.Google Scholar
  9. Khabriev, R.U., Rukovodstvo po eksperimental’nomu doklinicheskomu izucheniyu novykh farmakologicheskikh veshchestv (Guidance for Experimental Preclinical Study of New Pharmaceuticals), Moscow: Meditsina, 2005.Google Scholar
  10. Khaitov, R.M., Gushchin, I.S., Pinegin, B.V., and Zebrov, A.I., Doklinicheskie izucheniya effektivnosti khimioterapevticheskikh lekarstvennykh sredstv (Preclinical Study of the Efficacy of Chemotherapeutic Drugs), Moscow: MZ RF, 2005.Google Scholar
  11. Lopatina, T.K., Blyakher, M.S., Nikolaenko, V.N., and Nilovskii, M.N., Immunomodulatory effects of eubiotic drugs, Vestn. Ross. Akad. Med. Nauk, 1997, no. 3, pp. 30–34.Google Scholar
  12. Marteau, P. and Rambaud, J., Potential of using lactic acid bacteria for therapy and immunomodulation in man, FEMS Microbiol. Rev., 1993, vol. 12, pp. 207–220.CrossRefPubMedGoogle Scholar
  13. Masters, J.R., Animal Cell Culture: A Practical Approach, Oxford: Oxford Univ. Press, 2000.Google Scholar
  14. Mosmann, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Metods, 1983, vol. 65, pp. 55–63.CrossRefGoogle Scholar
  15. Nikitina, E.T. and Kalakutskii, L.V., The formation of secondary autonomous colonies of fungi on a synthetic medium during aging, Mikrobiologiya, 1977, vol. 46, no. 6, pp. 1087–1094.Google Scholar
  16. Oda, M., Hasegawa, H., Komatsu, S., Kambe, M., and Tsuchiya, F., Antitumor polysaccharide from lactobacillus species, Agric. Biol. Chem., 1983, vol. 47, no. 7, pp. 1623–1625.CrossRefGoogle Scholar
  17. Onishchenko, G.G., Aleshkina, V.A., Afanas’eva, S.S., and Pospelova, V.V., Immunobiologicheskie preparaty i perspektivy ikh primeneniya v infektologii (Immunobiological Drugs and the Prospects of Their Use in Infectology), Moscow: VUNMTs Minzdrava RF, 2002.Google Scholar
  18. Orrhage, K., Sillerstrom, E., Gustafsson, J.A., Nord, C.E., and Rafter, J., Binding of mutagenic heterocyclic amines by intestinal and lactic acid bacteria, Mutat. Res., 1994, vol. 311, pp. 239–248.CrossRefPubMedGoogle Scholar
  19. Pidoux, M., Brillionet, J.M., and Qwemener, B., Characterization of the polysaccharides from Lactobacillus brevis and from Sugari kefir grans, Biotechnol. Lett., 1988, vol. 10, pp. 415–420.CrossRefGoogle Scholar
  20. Ramashkina, S. and Prabhavathi, B.F., Handbook of Drug Screening, New York: Marcel Dekker Inc., 2001.Google Scholar
  21. Sawada, H., Furushiro, M., Hirai, K., Motoike, M., and Watanabe, T., Purification and characterization of an antihypertensive compound from lactobacillus casei, Agric. Biol. Chem., 1990, vol. 54, pp. 3211–3219.PubMedGoogle Scholar
  22. Schiffrin, E.J., Rochat, F., Link-Amster, H., Aeschlimann, J.M., and Donnet-Hughes, A., Immunomodulation of human blood cells following the ingestion of lactic acid bacteria, J. Dairy Sci., 1995, vol. 78, pp. 491–497.CrossRefPubMedGoogle Scholar
  23. Tsoi, I.G., Saparov, A.S., and Timofeeva, I.K., Immunostimulatory effect of lactobacilli on the cytotoxicity of natural killer cells and the production of interferon, Mikrobiologiya, 1994, no. 6, pp. 112–113.Google Scholar

Copyright information

© Pleiades Publishing, Inc. 2018

Authors and Affiliations

  • I. A. Ratnikova
    • 1
  • N. N. Gavrilova
    • 1
  • K. Bayakyshova
    • 1
  • Z. Zh. Turlybaeva
    • 1
  • L. A. Kosheleva
    • 1
  • N. M. Utegenova
    • 1
  1. 1.Institute of Microbiology and VirologyMinistry of Education and Science of the Republic of KazakhstanAlmatyKazakhstan

Personalised recommendations